Leveraging Artificial Intelligence for Strategic Transformation in Pharma Sales and Lifecycle Marketing: A Business-Centric Perspective

Abstract

Artificial Intelligence (AI) has been revolutionizing pharmaceutical sales and marketing. It has brought enhancements in terms of efficiency, personalization, and strategic decision-making. This study examines the role of AI in transforming commercial models in the pharmaceutical industry, paying heed to its applications in predictive analytics, customer segmentation, customer relationship management (CRM) automation, as well as hyper-personalized engagement. By integrating AI technologies, pharmaceutical companies help optimize healthcare professional (HCP) targeting, refine brand positioning, and improve patient adherence through intelligent touchpoints. In addition, AI enables agile business decision-making, letting the marketing teams anticipate trends and automate campaign management while deriving real-time insights from the complex datasets. Using a secondary qualitative research design, the article gives a detailed and business-oriented analysis of the impact of AI on the pharmaceutical commercial landscape, providing valuable insights for the marketers, strategy leaders, and innovators at the intersection of life sciences and digital health. The analysis discusses that AI-driven pharmacy tools help in improving demand forecasting accuracy by up to 30–80%, increase HCP engagement, and well as campaign ROI by 20–66%. It also boosts patient adherence by the predictive chatbots to 46,000 incremental prescriptions in six months. Thus, the findings validate the strategic value of AI in pharma sales and lifecycle marketing.

Ähnliche Arbeiten